NFL-101

NFL Biosciences SAS · Phase 2 active Small molecule

At a glance

Generic name	NFL-101
Also known as	Tobacco leaf extract
Sponsor	NFL Biosciences SAS
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy (PHASE2)
Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) (PHASE2)
Safety and Efficacity of NFL101 as Tobacco Therapy (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NFL-101 CI brief — competitive landscape report
NFL-101 updates RSS · CI watch RSS
NFL Biosciences SAS portfolio CI